Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan)

Postmarketing Observational Study of Tolterodine Treatment on Overactive Bladder in Real Life Setting

The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the Package Insert (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

All the subjects whom an investigator prescribes the first Detrusitol Capsule should be registered consecutively until the number of subjects reaches target number in order to extract patients enrolled into the investigation at random.

Inclusion Criteria:

• Male or female subjects intend to treat their overactive bladder who are prescribed Detrusitol Capsule by their physicians.

Exclusion Criteria:

• Subjects who have been prescribed Detrusitol Capsule before.